WAIVER REGARDING ANTI-DILUTION May __, 2014Waiver Regarding • August 12th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Reference is hereby made to that certain Warrant issued to [________] ("[WARRANTHOLDER]") by Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), pursuant to the Underwriting Agreement, dated as of August 13, 2013, by and among the Company, Roth Capital Partners, LLC and Maxim Group LLC (the “Warrant”), as set forth on Schedule 1 attached hereto. Capitalized terms not defined herein shall have the meaning assigned to such terms in the Warrant.
WAIVER REGARDING AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENTWaiver Regarding • December 2nd, 2010 • Energy Xxi (Bermuda) LTD • Oil & gas field exploration services • New York
This WAIVER REGARDING AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT (“Waiver”), dated effective as of December 1, 2010 (the “Effective Date”), is by and among Energy XXI Gulf Coast, Inc., a Delaware corporation (the “Borrower”), the lenders party to the First Lien Credit Agreement described below (the “Lenders”), and The Royal Bank of Scotland plc, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).
WAIVER REGARDING AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENTWaiver Regarding • November 22nd, 2010 • Energy Xxi (Bermuda) LTD • Oil & gas field exploration services • New York
This WAIVER REGARDING AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT (“Waiver”), dated effective as of November 17, 2010 (the “Effective Date”), is by and among Energy XXI Gulf Coast, Inc., a Delaware corporation (the “Borrower”), the lenders party to the First Lien Credit Agreement described below (the “Lenders”), and The Royal Bank of Scotland plc, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).
